Literature DB >> 29609831

Birth defects in children of men exposed in utero to diethylstilbestrol (DES).

Michel Tournaire1, Emmanuel Devouche2, Sylvie Epelboin3, Anne Cabau4, Annabel Dunbavand5, Anne Levadou6.   

Abstract

OBJECTIVE: Prenatal exposure to diethylstilbestrol (DES) is associated with adverse effects, including genital anomalies and cancers in men and women. Animal studies showed birth defects and tumors in the offspring of mice prenatally exposed to DES. In humans, birth defects, such as hypospadias were observed in children of prenatally exposed women. The aim of this research was to assess the birth defects in children of prenatally exposed men.
METHODS: In a retrospective study conceived by a patients' association (Réseau DES France), the reports of men prenatally exposed to DES on adverse health effects in their children were compared with those of unexposed controls and general population.
RESULTS: An increased incidence of two genital anomalies, cryptorchidism (OR=5.72; 95% CI 1.51-21.71), and hypoplasia of the penis (OR=22.92; 95% CI 3.81-137.90), was observed in the 209 sons of prenatally exposed men compared with controls, but hypospadias incidence was not increased in comparison with either the controls or the general population. No increase of genital anomalies was observed in daughters.
CONCLUSION: With caution due to the methods and to the small numbers of defects observed, this work suggests an increased incidence of two male genital tract defects in sons of men prenatally exposed to DES. This transgenerational effect, already observed in animals and in the offspring of women prenatally exposed to DES, could be the result of epigenetic changes transmitted to the subsequent generation through men.
Copyright © 2018 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Birth defects; Cancer; DES; Diethylstilbestrol; Epigenetic alterations; Estrogens; Pregnancy

Mesh:

Substances:

Year:  2018        PMID: 29609831     DOI: 10.1016/j.therap.2018.02.007

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  5 in total

Review 1.  Endocrine disruption through membrane estrogen receptors and novel pathways leading to rapid toxicological and epigenetic effects.

Authors:  Cheryl S Rosenfeld; Paul S Cooke
Journal:  J Steroid Biochem Mol Biol       Date:  2018-11-19       Impact factor: 4.292

Review 2.  Integrated Genomic and Bioinformatics Approaches to Identify Molecular Links between Endocrine Disruptors and Adverse Outcomes.

Authors:  Jacopo Umberto Verga; Matthew Huff; Diarmuid Owens; Bethany J Wolf; Gary Hardiman
Journal:  Int J Environ Res Public Health       Date:  2022-01-05       Impact factor: 3.390

Review 3.  Are the Effects of DES Over? A Tragic Lesson from the Past.

Authors:  Pilar Zamora-León
Journal:  Int J Environ Res Public Health       Date:  2021-09-30       Impact factor: 3.390

Review 4.  Praegnatio Perturbatio-Impact of Endocrine-Disrupting Chemicals.

Authors:  Vasantha Padmanabhan; Wenhui Song; Muraly Puttabyatappa
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 19.871

Review 5.  Endocrine disrupting chemicals in the pathogenesis of hypospadias; developmental and toxicological perspectives.

Authors:  Deidre M Mattiske; Andrew J Pask
Journal:  Curr Res Toxicol       Date:  2021-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.